Mode
Text Size
Log in / Sign up
Phase 3 Completed N=269 Randomized Triple-blind Prevention

Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes

Complication of Renal Dialysis · End Stage Renal Disease · End-stage kidney disease · ESRD
Source: ClinicalTrials.gov NCT02513303 ↗
Enrolled (actual)
269
Serious AEs
46.8%
Results posted
Oct 2025
Primary outcomePrimary: Fistula Suitability for Dialysis at 6 Months (FSD6) — 74; 76; 21; 43 Participants — p=0.2942
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

The objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of an AV fistula for vascular access (index procedure).

Outcome Measures

OutcomeResultp-value
PRIMARY
Fistula Suitability for Dialysis at 6 Months (FSD6)
74; 76; 21; 43; 35; 5 0.2942

Eligibility Criteria

Inclusion Criteria

  • Currently on hemodialysis for ≤12 months or expected to initiate hemodialysis within approximately 6 months of the creation of the AV fistula.
  • Vascular anatomy suitable for creation of the AV fistula, determined by pre procedure duplex ultrasound
  • Successful creation of a single stage radiocephalic or brachiocephalic end to side fistula

Exclusion Criteria

  • Prior AV access created on the limb where the fistula surgery is planned
  • ST-elevation MI or cerebrovascular accident within 30 days of the index procedure
  • Known hypersensitivity to the following: sirolimus, beef or bovine collagen
  • Hypotension with systolic blood pressures <100 mm Hg at the time of screening
  • Known or suspected active infection at the time of the AV fistula surgery
  • Known to be HIV positive
  • Prisoner, mentally incompetent, and/or alcohol or drug abuser
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02513303). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search